1. Subvisible (2–100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis. Issue 6 (November 2015) Authors: Corvari, Vincent; Narhi, Linda O.; Spitznagel, Thomas M.; Afonina, Nataliya; Cao, Shawn; Cash, Patricia; Cecchini, Irene; DeFelippis, Michael R.; Garidel, Patrick; Herre, Andrea; Koulov, Atanas V.; Lubiniecki, Tony; Mahler, Hanns-Christian; Mangiagalli, Paolo; Nesta, Douglas; Perez-Ramirez, Berna... Journal: Biologicals Issue: Volume 43:Issue 6(2015:Nov.) Page Start: 457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lipid-based nanoparticle formulations for small molecules and RNA drugs. (2nd November 2019) Authors: Ickenstein, Ludger M.; Garidel, Patrick Journal: Expert opinion on drug delivery Issue: Volume 16:Number 11(2019) Page Start: 1205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hydrogel formulations for biologicals: current spotlight from a commercial perspective. (9th February 2018) Authors: Ickenstein, Ludger M; Garidel, Patrick Journal: Therapeutic delivery Issue: Volume 9:Number 3(2018) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adaption of human antibody λ and κ light chain architectures to CDR repertoires. Issue 3 (19th September 2019) Authors: van der Kant, Rob; Bauer, Joschka; Karow-Zwick, Anne R; Kube, Sebastian; Garidel, Patrick; Blech, Michaela; Rousseau, Frederic; Schymkowitz, Joost Editors: Other, A N Journal: Protein engineering, design & selection Issue: Volume 32:Issue 3(2019) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Rational optimization of a monoclonal antibody improves the aggregation propensity and enhances the CMC properties along the entire pharmaceutical process chain. Issue 1 (1st January 2020) Authors: Bauer, Joschka; Mathias, Sven; Kube, Sebastian; Otte, Kerstin; Garidel, Patrick; Gamer, Martin; Blech, Michaela; Fischer, Simon; Karow-Zwick, Anne R Journal: MAbs Issue: Volume 12:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. An update on endotoxin neutralization strategies in Gram-negative bacterial infections. Issue 4 (3rd April 2021) Authors: Brandenburg, Klaus; Schromm, Andra B; Weindl, Günther; Heinbockel, Lena; Correa, Wilmar; Mauss, Karl; Martinez de Tejada, Guillermo; Garidel, Patrick Journal: Expert review of anti-infective therapy Issue: Volume 19:Issue 4(2021) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Characterizing protein–protein-interaction in high-concentration monoclonal antibody systems with the quartz crystal microbalance. Issue 48 (4th December 2017) Authors: Hartl, Josef; Peschel, Astrid; Johannsmann, Diethelm; Garidel, Patrick Journal: Physical chemistry chemical physics Issue: Volume 19:Issue 48(2017) Page Start: 32698 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prediction and Reduction of the Aggregation of Monoclonal Antibodies. Issue 8 (21st April 2017) Authors: van der Kant, Rob; Karow-Zwick, Anne R.; Van Durme, Joost; Blech, Michaela; Gallardo, Rodrigo; Seeliger, Daniel; Aßfalg, Kerstin; Baatsen, Pieter; Compernolle, Griet; Gils, Ann; Studts, Joey M.; Schulz, Patrick; Garidel, Patrick; Schymkowitz, Joost; Rousseau, Frederic Journal: Journal of molecular biology Issue: Volume 429:Issue 8(2017) Page Start: 1244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Subvisible (2–100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy. Issue 6 (1st April 2015) Authors: Narhi, Linda O.; Corvari, Vincent; Ripple, Dean C.; Afonina, Nataliya; Cecchini, Irene; Defelippis, Michael R.; Garidel, Patrick; Herre, Andrea; Koulov, Atanas V.; Lubiniecki, Tony; Mahler, Hanns‐Christian; Mangiagalli, Paolo; Nesta, Douglas; Perez‐Ramirez, Bernardo; Polozova, Alla; Rossi, Mara; ... Journal: Journal of pharmaceutical sciences Issue: Volume 104:Issue 6(2015:Jun.) Page Start: 1899 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Buffer‐free therapeutic antibody preparations provide a viable alternative to conventionally buffered solutions: From protein buffer capacity prediction to bioprocess applications. Issue 4 (April 2015) Authors: Bahrenburg, Sven; Karow, Anne R.; Garidel, Patrick Journal: Biotechnology journal Issue: Volume 10:Issue 4(2015:Apr.) Page Start: 610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗